Literature DB >> 28179137

The impact of different mutations at Arg54 on structure, chaperone-like activity and oligomerization state of human αA-crystallin: The pathomechanism underlying congenital cataract-causing mutations R54L, R54P and R54C.

Kazem Khoshaman1, Reza Yousefi2, Ali Mohammad Tamaddon3, Samira Sadat Abolmaali3, Ahmad Oryan4, Ali Akbar Moosavi-Movahedi5, Boris I Kurganov6.   

Abstract

A major part of cataractogenic mutations in human αA-Crystallin (αA-Cry) occurs at Arg residues. While Arg54 is highly conserved within different species, the cataractogenic mutations R54L, R54P and R54C have been recently identified in CRYAA gene, encoding human αA-Cry. The detailed structural and functional aspects, stability and amyloidogenic properties of αA-Cry were determined upon the above-mentioned missense mutations, using various spectroscopic techniques, gel electrophoresis, electron microscopy, size exclusion chromatography analyses, and chaperone-like activity assay. The different mutations at Arg54 result in diverse structural alterations among mutant proteins. In addition, the mutant proteins displayed reduced thermal stability, increased amyloidogenic properties and attenuated chaperone-like activity against aggregation of γ-Cry, catalase and lysozyme. The mutant proteins were also capable of forming larger oligomeric complexes with γ-Cry which is the natural partner of α-Cry in the eye lenses. The most significant structural and functional damages were observed upon R54L mutation which was also accompanied with increased oligomeric size distribution of the mutant protein. The cataractogenic nature of R54P mutation can be explained with its detrimental effect on chaperone-like activity, conformational stability and proteolytic digestibility of the mutant protein. Also, R54C αA-Cry displayed an important intrinsic propensity for disulfide protein cross-linking with significantly reduced chaperone-like activity against all client proteins. These mutations revealed a range of detrimental effects on the structure, stability and functional properties of αA-Cry which all together can explain the pathomechanisms underlying development of the associated congenital cataract disorders.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cataract; Chaperone; Crystallin; Protein aggregation; Protein stability; αA-crystallin

Mesh:

Substances:

Year:  2017        PMID: 28179137     DOI: 10.1016/j.bbapap.2017.02.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  5 in total

1.  Structural and functional studies of D109A human αB-crystallin contributing to the development of cataract and cardiomyopathy diseases.

Authors:  Mahtab Hafizi; Natalia A Chebotareva; Maryam Ghahramani; Faezeh Moosavi-Movahedi; Seyed Hossein Khaleghinejad; Boris I Kurganov; Ali Akbar Moosavi-Movahedi; Reza Yousefi
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

Review 2.  Insights on Human Small Heat Shock Proteins and Their Alterations in Diseases.

Authors:  B Tedesco; R Cristofani; V Ferrari; M Cozzi; P Rusmini; E Casarotto; M Chierichetti; F Mina; M Galbiati; M Piccolella; V Crippa; A Poletti
Journal:  Front Mol Biosci       Date:  2022-02-25

Review 3.  The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.

Authors:  Barbara Tedesco; Veronica Ferrari; Marta Cozzi; Marta Chierichetti; Elena Casarotto; Paola Pramaggiore; Francesco Mina; Mariarita Galbiati; Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Angelo Poletti
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

4.  Human αB-crystallin as fusion protein and molecular chaperone increases the expression and folding efficiency of recombinant insulin.

Authors:  Mohsen Akbarian; Reza Yousefi
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

5.  Kinetic data analysis of chaperone-like activity of Wt, R69C and D109H αB-crystallins.

Authors:  Maryam Ghahramani; Reza Yousefi; Alexey Krivandin; Konstantin Muranov; Boris Kurganov; Ali Akbar Moosavi-Movahedi
Journal:  Data Brief       Date:  2019-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.